Chylomicron

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Chylomicronemia)
Jump to: navigation, search

WikiDoc Resources for

Chylomicron

Articles

Most recent articles on Chylomicron

Most cited articles on Chylomicron

Review articles on Chylomicron

Articles on Chylomicron in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Chylomicron

Images of Chylomicron

Photos of Chylomicron

Podcasts & MP3s on Chylomicron

Videos on Chylomicron

Evidence Based Medicine

Cochrane Collaboration on Chylomicron

Bandolier on Chylomicron

TRIP on Chylomicron

Clinical Trials

Ongoing Trials on Chylomicron at Clinical Trials.gov

Trial results on Chylomicron

Clinical Trials on Chylomicron at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Chylomicron

NICE Guidance on Chylomicron

NHS PRODIGY Guidance

FDA on Chylomicron

CDC on Chylomicron

Books

Books on Chylomicron

News

Chylomicron in the news

Be alerted to news on Chylomicron

News trends on Chylomicron

Commentary

Blogs on Chylomicron

Definitions

Definitions of Chylomicron

Patient Resources / Community

Patient resources on Chylomicron

Discussion groups on Chylomicron

Patient Handouts on Chylomicron

Directions to Hospitals Treating Chylomicron

Risk calculators and risk factors for Chylomicron

Healthcare Provider Resources

Symptoms of Chylomicron

Causes & Risk Factors for Chylomicron

Diagnostic studies for Chylomicron

Treatment of Chylomicron

Continuing Medical Education (CME)

CME Programs on Chylomicron

International

Chylomicron en Espanol

Chylomicron en Francais

Businness

Chylomicron in the Marketplace

Patents on Chylomicron

Experimental / Informatics

List of terms related to Chylomicron

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Chylomicrons are large lipoprotein particles (having a diameter of 75 to 1,200nm) that are created by the absorptive cells of the small intestine.The chylomicrons are released by exocytosis from enterocytes into lacteals, lymphatic vessels originating in the villi of the small intestine, and are then secreted into the bloodstream at the thoracic duct's connection with the left subclavian vein. Chylomicrons transport exogenous lipids to liver, adipose, cardiac and skeletal muscle tissue where they are broken down by lipoprotein lipase into very low density lipoproteins (VLDLs).

Contents when released

Nascent chylomicrons are primarily composed of triglycerides (85%) and contain some cholesterol and cholesteryl esters. The main apolipoprotein component is apolipoprotein B-48 (APOB48).

Changes during circulation

While circulating in lymph and blood, chylomicron exchanges components with High Density Lipoproteins (HDL). The HDL donates apolipoprotein C-II (APOC2) and apolipoprotein E (APOE) to the nascent chylomicron and thus matures it into a "chylomicron." APOC2 is the cofactor for lipoprotein lipase (LPL) activity. Once triglyceride stores are distributed, the chylomicron returns APOC2 (but keeps APOE) back to the HDL and thus becomes a chylomicron remnant. APOB48 and APOE are important to identify the chylomicron remnant in the liver for endocytosis and breakdown.

de:Chylomikronfr:Chylomicron

it:Chilomicroni nl:Chylomicronfi:Kylomikroni sv:Kylomikron

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
In other languages